2,3,5-triiodobenzoic acid has been researched along with Disease Models, Animal in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, HJ; Cho, HR; Choi, JW; Chung, JW; Kim, DD; Kim, HC; Park, JH | 1 |
1 other study(ies) available for 2,3,5-triiodobenzoic acid and Disease Models, Animal
| Article | Year |
|---|---|
Sorafenib and 2,3,5-triiodobenzoic acid-loaded imageable microspheres for transarterial embolization of a liver tumor.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Chemoembolization, Therapeutic; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Liver Neoplasms; Magnetic Resonance Imaging; Male; Materials Testing; Microspheres; Niacinamide; Phenylurea Compounds; Rats; Sorafenib; Tissue Distribution; Tomography, X-Ray Computed; Treatment Outcome; Triiodobenzoic Acids; Xenograft Model Antitumor Assays | 2017 |